Table 1.
S. No | Types of Cancer | Cell Culture Model | Mechanisms | Dose/Concentration Used | Ref. | |
---|---|---|---|---|---|---|
1 | Human breast tumor cells | H-Ras MCF10A | Apoptosis induction | ↑p53, ↑Bax, and ↑ cleavage of poly (ADP)-ribose polymerase | 100 μM | [91] |
2 | Human triple-negative breast cancer | MDA-MB-231 and BALB/c nude mice | Anti-proliferative and inhibited migration | ↓paxillin/FAK, ↓Src, ↓GLUTs, ↑p53, ↑p21, ↑E-cadherin | 50–150 μM | [16] |
3 | Human cervical cancer | SiHa, and nude mice (in vivo) | Anti-metastasis and anti-angiogenesis | ↓invasion, ↓MMP-2 ↓MMP-3, ↓cathepsin S | 60 μM, 100 μM (in vitro cell lines); 10 or 20 mg/kg (in vivo model) |
[17] |
4 | Human colon cancer | HT-29-Luc cells | Apoptosis induction | ↓BCL2, TRAIL | - | [12] |
5 | Human colorectal cancer | COLO 205 and HT-29 and in vivo BALB/c nude mice |
Inhibit cell invasiveness | ↓Glucose transporters, ↑p53 | 12.5, 25, 50, 100, and 200 μM | [36] |
6 | Human esophageal cancer | EC-109 cells | Apoptosis induction | ↓B-cell lymphoma 2 (bcl-2), ↑p53, ↑apoptotic protease activating factor-1 | 60, 70, 80, 90, and 100 µg/mL | [7] |
7 | Human Gastric Cancer | AGS | Apoptosis induction and cell cycle arrest | ↑G2/M phase arrest | - | [11] |
8 | Human glioblastoma cells | U87 and U251 | Apoptosis induction and cell cycle arrest | ↑p27, ↓cdk2, ↓cdk4, ↓cdk6, ↓cyclin D and ↓cyclin E, ↓PI3K/AKT/mTOR | 200 μM | [38] |
9 | Human leukemia cells | HL60 | Apoptosis induction | ↓protein kinase C | 0.1–0.2 mM | [92] |
10 | Hepatocellular carcinoma | HepG2, SK-Hep1, Sor resistant HepG2SR, Huh7SR xenografts |
anti-proliferative anti- angiogenesis, | ↓STAT3, ↓AKT/mTOR/JAK2/VEGFR2 | 50 μM | [93] |
11 | Human liver cancer | HepG2 cells as well in vivo mice models | Apoptosis induction | ↓Akt and Bcl-2, GLUT2 | 200 μM | [14] |
12 | Non-small cell lung cancer (NSCLC) cells | A549 | Apoptosis induction | ↑BAX, ↑cleaved caspase-3 and -9, ↑ PARP, ↓Bcl-2 | 20 mg/kg (administered to in vivo models) | [8] |
13 | Human oral cancer | SCC-1 | Cell cycle arrest | ↑G0/G1 cell cycle arrest, ↓cyclin D1, ↓CDK4 and ↓CDK6, ↑ROS | - | [9] |
14 | Human Prostate Cancer | LNCaP, CWR22Rv1, PC-3, and DU145 | Apoptosis induction | ↓Sp3/4, VEGF, Survivin | 20, 50, and 100 μM | [94] |
15 | Mouse melanoma | 4A5 cells | Apoptosis induction | ↑Bax, ↑caspases activation | 0.1–0.2 mM | [92] |